Robert Andrade - 18 Nov 2024 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Robert Andrade
Issuer symbol
FENC
Transactions as of
18 Nov 2024
Net transactions value
$0
Form type
4
Filing time
18 Nov 2024, 17:02:51 UTC
Previous filing
04 Nov 2024
Next filing
02 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FENC Common shares Options Exercise $38,749 +15,816 +14% $2.45 127,381 18 Nov 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FENC Stock Options Options Exercise $38,749 -15,816 -2.2% $2.45 689,184 18 Nov 2024 Options 15,816 $2.45 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares acquired through the exercise of option contract with a strike price of $2.45 and an expiration date of July 5, 2026
F2 Represents options granted on July 5, 2016, with a strike price of $2.45 and expiration date of July 5, 2026